Hengrui Pharma Reports Steady Growth in the First Nine Months of 2026

Hengrui Pharma Reports Steady Growth in the First Nine Months of 2026

SHANGHAI, Oct. 27, 2026 /PRNewswire/ -- Hengrui Pharma ("Hengrui" or "the Company") today announced its financial results for the first nine months of 2026. During this period, Hengrui reported revenue of RMB24.41 billion, representing a...

menu
menu